- Necroptosis is a regulated form of necrotic cell death characterised by membrane rupture, inflammation and activation of a defined kinase cascade. Unlike apoptosis, which is caspase‑dependent and non‑inflammatory, necroptosis produces cellular swelling, membrane permeabilisation and release of intracellular contents that stimulate immune responses. This pathway acts as a backup cell‑death mechanism when apoptosis is blocked, particularly during viral infection, inflammation and tissue injury.
- Necroptosis is initiated when death receptors such as TNFR1, Fas or TRAIL receptors are activated under conditions where caspase‑8 is inhibited or absent. Normally, caspase‑8 suppresses necroptosis by cleaving RIPK1 and RIPK3. When caspase‑8 activity is compromised, RIPK1 interacts with RIPK3 through their RHIM domains, forming the necrosome — a signalling complex that drives necroptotic execution.
- RIPK3 phosphorylates the pseudokinase MLKL, the terminal effector of necroptosis. Phosphorylated MLKL oligomerises, translocates to the plasma membrane and inserts into lipid bilayers, forming disruptive pores. This causes ionic imbalance, osmotic swelling, membrane rupture and release of DAMPs (damage‑associated molecular patterns), which activate inflammatory pathways and recruit immune cells.
- Necroptosis is tightly integrated with other regulated cell‑death pathways. Crosstalk with apoptosis ensures that necroptosis is activated only when apoptotic machinery is compromised. Interaction with pyroptosis and ferroptosis shapes inflammatory outcomes during infection and tissue damage. Necroptosis also interfaces with autophagy and oxidative stress responses, influencing cell fate under metabolic and redox stress.
- Necroptosis plays important physiological and pathological roles. During viral infection, many viruses inhibit caspase‑8 to block apoptosis; necroptosis acts as a fail‑safe mechanism to eliminate infected cells. In inflammatory diseases, excessive necroptosis contributes to tissue damage, cytokine release and chronic inflammation. Necroptosis is implicated in neurodegeneration, ischemia–reperfusion injury, pancreatitis, inflammatory bowel disease and certain cancers.
- In summary, necroptosis is a regulated necrotic cell‑death pathway driven by RIPK1–RIPK3–MLKL signalling. Through membrane permeabilisation and inflammatory activation, necroptosis eliminates infected or damaged cells when apoptosis is blocked. Its roles in immunity, inflammation and disease make necroptosis a major focus of modern cell‑death research.
